Cart
sales@molnova.com
Z-Lys-OH
CAS No. 2212-75-1
Z-Lys-OH( —— )
Catalog No. M35882 CAS No. 2212-75-1
Z-Lys-OH is a competitive inhibitor of papain, a lysine derivative.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameZ-Lys-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionZ-Lys-OH is a competitive inhibitor of papain, a lysine derivative.
-
DescriptionZ-Lys-OH is a lysine derivative.
-
In VitroAmino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetCysteine Protease
-
RecptorCysteine Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2212-75-1
-
Formula Weight280.32
-
Molecular FormulaC14H20N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](NC(OCC1=CC=CC=C1)=O)(CCCCN)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Luckose F, et al. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.?
molnova catalog
related products
-
Aureusimine B
Aureusimine B, a Calpain inhibitor, is produced by Staphylococcus aureus biofilms and could be a potential biomarker for S. aureus biofilm-based infections.
-
JTE-607 HCl
JTE-607 is a cytokine production inhibitor. JTE-607 induces apoptosis accompanied by an increase in p21waf1/cip1 in acute myelogenous leukemia cells.
-
K777
K777 is an orally active and irreversible cysteine protease inhibitor. K777 is a broad-spectrum antiviral by targeting cathepsin-mediated cell entry.
